$2.23 Billion is the total value of Casdin Capital, LLC's 47 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 18.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BLFS | BIOLIFE SOLUTIONS INC | $171,982,000 | -39.0% | 7,566,292 | 0.0% | 7.71% | -3.0% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $163,290,000 | -3.7% | 1,000,000 | 0.0% | 7.32% | +53.2% | |
| EQRX INC | $163,249,000 | -39.4% | 39,527,669 | 0.0% | 7.32% | -3.7% | ||
| FATE | FATE THERAPEUTICS INC | $131,818,000 | -33.7% | 3,400,000 | 0.0% | 5.91% | +5.4% | |
| RLAY | RELAY THERAPEUTICS INC | $115,448,000 | -2.5% | 3,857,253 | 0.0% | 5.18% | +55.0% | |
| SOMALOGIC INC | $99,360,000 | -31.1% | 12,389,082 | 0.0% | 4.46% | +9.6% | ||
| BPMC | BLUEPRINT MEDICINES CORP | $99,014,000 | -40.4% | 1,550,000 | 0.0% | 4.44% | -5.1% | |
| MAXCYTE INC | $97,660,000 | -31.4% | 13,971,334 | 0.0% | 4.38% | +9.1% | ||
| NVTA | INVITAE CORP | $97,263,000 | -47.8% | 12,203,669 | 0.0% | 4.36% | -17.0% | |
| EXAS | Sell | EXACT SCIENCES CORP | $92,994,000 | -41.4% | 1,330,000 | -34.8% | 4.17% | -6.8% |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $72,715,000 | -55.5% | 7,990,652 | 0.0% | 3.26% | -29.3% | |
| VERV | VERVE THERAPEUTICS INC | $71,613,000 | -38.1% | 3,138,167 | 0.0% | 3.21% | -1.5% | |
| ABSCI CORPORATION | $65,068,000 | +2.8% | 7,718,593 | 0.0% | 2.92% | +63.6% | ||
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $62,496,000 | -48.6% | 800,000 | -40.7% | 2.80% | -18.2% |
| AGIO | AGIOS PHARMACEUTICALS INC | $60,840,000 | -11.4% | 2,090,000 | 0.0% | 2.73% | +40.9% | |
| RVMD | REVOLUTION MEDICINES INC | $60,459,000 | +1.4% | 2,370,000 | 0.0% | 2.71% | +61.3% | |
| DNLI | DENALI THERAPEUTICS INC | $48,255,000 | -27.9% | 1,500,000 | 0.0% | 2.16% | +14.7% | |
| BEAM | BEAM THERAPEUTICS INC | $46,918,000 | -28.1% | 818,820 | 0.0% | 2.10% | +14.4% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $45,898,000 | +18.3% | 1,325,000 | 0.0% | 2.06% | +88.3% | |
| TWST | Buy | TWIST BIOSCIENCE CORP | $43,454,000 | -16.2% | 880,000 | +31.3% | 1.95% | +33.3% |
| CDNA | CAREDX INC | $42,662,000 | -18.7% | 1,153,335 | 0.0% | 1.91% | +29.4% | |
| TENAYA THERAPEUTICS INC | $42,253,000 | -37.8% | 3,586,818 | 0.0% | 1.90% | -1.1% | ||
| TANGO THERAPEUTICS INC | $41,598,000 | -30.7% | 5,487,910 | 0.0% | 1.86% | +10.2% | ||
| IPSC | CENTURY THERAPEUTICS INC | $40,368,000 | -20.6% | 3,206,380 | 0.0% | 1.81% | +26.3% | |
| BGNE | BEIGENE LTDsponsored adr | $28,290,000 | -30.4% | 150,000 | 0.0% | 1.27% | +10.7% | |
| GH | Sell | GUARDANT HEALTH INC | $27,821,000 | -64.8% | 420,000 | -46.8% | 1.25% | -44.0% |
| DERMTECH INC | $25,617,000 | -7.1% | 1,745,000 | 0.0% | 1.15% | +47.9% | ||
| Sell | GINKGO BIOWORKS HOLDINGS INC | $16,937,000 | -52.9% | 4,202,808 | -2.9% | 0.76% | -25.1% | |
| SEMA4 HOLDINGS CORP | $15,350,000 | -31.2% | 5,000,000 | 0.0% | 0.69% | +9.4% | ||
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $13,880,000 | -50.5% | 1,000,000 | 0.0% | 0.62% | -21.4% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $13,472,000 | -31.3% | 960,882 | 0.0% | 0.60% | +9.2% | |
| SEER | SEER INC | $12,192,000 | -33.2% | 800,000 | 0.0% | 0.55% | +6.4% | |
| New | 2SEVENTY BIO INC | $10,488,000 | – | 614,754 | +100.0% | 0.47% | – | |
| EXSCIENTIA PLCads | $10,280,000 | -27.1% | 713,900 | 0.0% | 0.46% | +15.8% | ||
| GBIO | GENERATION BIO CO | $9,720,000 | +3.7% | 1,324,275 | 0.0% | 0.44% | +65.2% | |
| SCIENCE 37 HOLDINGS INC | $9,630,000 | -57.1% | 1,800,000 | 0.0% | 0.43% | -31.8% | ||
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $9,105,000 | -45.4% | 1,442,870 | 0.0% | 0.41% | -13.2% | |
| MRTX | New | MIRATI THERAPEUTICS INC | $8,428,000 | – | 102,500 | +100.0% | 0.38% | – |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,398,000 | -31.1% | 555,455 | 0.0% | 0.38% | +9.9% | |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $8,043,000 | -53.5% | 2,773,468 | -28.9% | 0.36% | -25.9% |
| ZLAB | ZAI LAB LTDadr | $6,597,000 | -30.0% | 150,000 | 0.0% | 0.30% | +11.3% | |
| CDXS | Sell | CODEXIS INC | $6,186,000 | -95.4% | 300,000 | -93.1% | 0.28% | -92.7% |
| KRON | KRONOS BIO INC | $4,218,000 | -46.8% | 583,436 | 0.0% | 0.19% | -15.2% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $3,925,000 | -58.2% | 548,156 | 0.0% | 0.18% | -33.6% | |
| ORIC | ORIC PHARMACEUTICALS INC | $3,212,000 | -63.7% | 601,515 | 0.0% | 0.14% | -42.2% | |
| DBTX | Sell | DECIBEL THERAPEUTICS INC | $1,003,000 | -81.6% | 330,000 | -71.8% | 0.04% | -70.6% |
| LIANBIOsponsored ads | $766,000 | -39.8% | 206,415 | 0.0% | 0.03% | -5.6% | ||
| SANA | Exit | SANA BIOTECHNOLOGY INC | $0 | – | -60,000 | -100.0% | -0.03% | – |
| STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -0.08% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -200,000 | -100.0% | -0.10% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -406,502 | -100.0% | -0.30% | – |
| ME | Exit | 23ANDME HOLDING CO | $0 | – | -1,841,457 | -100.0% | -0.35% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -266,430 | -100.0% | -0.57% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -1,650,000 | -100.0% | -0.96% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -2,650,000 | -100.0% | -1.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 32 | Q3 2023 | 9.6% |
| ALNYLAM PHARMACEUTICALS INC | 32 | Q3 2023 | 9.9% |
| AGIOS PHARMACEUTICALS INC | 27 | Q2 2022 | 12.1% |
| GLOBAL BLOOD THERAPEUTICS IN | 27 | Q2 2022 | 7.1% |
| FATE THERAPEUTICS INC | 26 | Q3 2023 | 8.3% |
| BIOLIFE SOLUTIONS INC | 22 | Q3 2023 | 14.9% |
| CODEXIS INC | 22 | Q3 2023 | 8.1% |
| SAREPTA THERAPEUTICS INC | 21 | Q3 2023 | 13.6% |
| BLUEBIRD BIO INC | 21 | Q4 2020 | 7.8% |
| ILLUMINA INC | 21 | Q3 2023 | 6.0% |
View Casdin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Absci Corp | May 08, 2023 | 4,448,260 | 4.8% |
| CODEXIS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| DermTech, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Invitae Corp | February 14, 2023 | 9,038,388 | 3.7% |
| Magenta Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Tango Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Verve Therapeutics, Inc. | February 14, 2023 | 2,290,571 | 3.7% |
| Tenaya Therapeutics, Inc. | December 07, 2022 | 6,427,200 | 9.9% |
| Fulcrum Therapeutics, Inc. | February 11, 2021 | 1,241,176 | 4.5% |
| Gritstone Oncology, Inc.Sold out | February 11, 2021 | 0 | 0.0% |
View Casdin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-18 |
| SC 13D/A | 2024-04-08 |
| 4 | 2024-03-28 |
| 3 | 2024-03-25 |
| 4 | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 4 | 2024-03-06 |
| 4 | 2024-03-06 |
| 13F-HR | 2024-02-14 |
View Casdin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.